Skip to main content
OpenTrials
Completed

NCT Number: NCT04775277

Outcome of Idiopathic Pulmonary Fibrosis With Pregnancy

case-control study was conducted between December 2018 to April 2020. To document outcome of IPF with pregnancy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Idiopathic Pulmonary Fibrosis Lung Diseases Lung Diseases, Interstitial Pulmonary Fibrosis Respiratory Tract Diseases

Age range

18 year–38 year

Sex eligibility

Female

Study type

Observational

Primary location

Sohag University

Sohag, 82524, Egypt

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with pulmonary diseases during pregnancy

Exclusion criteria

  • Patients with pulmonary diseases other than IPF and bronchial asthma were excluded.

Treatment and study plan

Primary outcomes

  1. any adverse events including gestational complication or disease specific complication

    Time frame: from the start of inclusion to the study till termination of pregnancy, average 9 months period

    e.g (development of respiratory failure, need for ICU admission). maternal outcome

  2. neonatal outcome

    Time frame: December 2018 to April 2020

    any unfavorable neonatal outcome as low birth weight

  3. neonatal outcome

    Time frame: December 2018 to April 2020

    any unfavorable neonatal outcome as prematurity or neonatal death.

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Important dates

Study start
2018
Primary completion
2020
Study completion
2021
First posted
Mar 1, 2021
Registry last updated
Mar 1, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.